Obsidian Therapeutics Inc. (OBX) Open Interest History

Open interest tracks the total number of outstanding options contracts. Rising OI alongside price moves can indicate growing commitment to the trend; declining OI suggests positions are being closed.

Obsidian Therapeutics Inc. (OBX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $19.1M, listed on NASDAQ, employing roughly 3 people, carrying a beta of 2.64 to the broader market. A clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor-infiltrating lymphocyte (TIL) cell therapies for the treatment of patients with solid tumors. Led by Madan Jagasia, public since 2026-08-04.

Open interest history tracks how outstanding options contracts change over time. No recent options activity for OBX as of 2026-08-31; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how open interest is reported and how to read the data →